WHO approves fourth human papillomavirus vaccine to prevent cancer

World Health Organization

(WHO) has taken a significant step in the fight against cervical cancer by turning on Cecoline vaccine on your list vaccinations allowed against human papillomavirus (HPV).

Read also

Catalina Ciampa

With this new addition he becomes fourth vaccine approved to combat this viruswhat causes most cases cervical cancer which are diagnosed annually throughout world.

Statement Tsekolin not only expands opportunities vaccinationbut also strengthens obligation belonging WHO decrease inequalities in access to preventive procedures.

Thanks to this new inclusion WHO strives to provide an additional tool in prevention this disease potentially mortalwhich affects millions women all over the planet.

New hope in the fight against cervical cancer

IN release released last Friday, the organization reported that Cecoline vaccine “meets the criteria established WHO regarding unauthorized alternative uses vaccine against him virus in diagrams single dose“.

This progress will increase protection from girls And women against him cervical cancera disease that, according to the organization, is behind more than 95% of 660,000 cases Cancer which are registered every year global level.

He Dr. Tedros Adhanom GhebreyesusThe WHO Director-General emphasized the importance of this approval, saying that “by adding another option for vaccination doses against virus human papillomawe took one more step to push back cervical cancer

into history.”

In addition, he emphasized the urgent need to solve the problem inequalities who persist in accessing preventive treatment, indicating that a woman dies every two minutes because of this disease. He 90% of these deaths occur in countries low- and middle-income countries, with 19 of the 20 worst-affected countries located in Africa.

Global commitments and achievements in vaccination

WHO and its international partners have set an ambitious goal of collecting almost $600 million V 2024 eliminate cervical cancer. With this goal in mind, the health agency UN was also suggested vaccinate up to 90% girls before they meet 15 yearsthereby protecting more women from HPV.

Since introduction vaccination against this infection sexual transmission in 2018 shortage supply made it difficult distribution effective. According to WHOgrowing number”vaccine products“Pre-qualification has evolved from requiring two dose administer in a single dose.

IN September this year 57 countries implemented the scheme single dosewhich is 20 countries more than in 2023as a result, at least six million girls additional people who received vaccine.

This promote represents not only progress in global public healthbut also hope

extended by millions women in all world who can benefit from prevention belonging cervical cancer through vaccination.

This information is in no way a substitute for a doctor’s diagnosis or prescription. It is important to consult a specialist when symptoms appear and never self-medicate.